title: ÐÐ»Ð¸ÑÐ½Ð¸Ðµ ÑÐ°ÐºÑÐ¾ÑÐ¾Ð² ÑÐ¾ÑÑÐ° ÑÐ½Ð´Ð¾Ð¼ÐµÑÑÐ¸Ñ Ð½Ð° ÑÐµÐ·ÑÐ»ÑÑÐ°ÑÐ¸Ð²Ð½Ð¾ÑÑÑ ÑÐºÑÑÑÐ°ÐºÐ¾ÑÐ¿Ð¾ÑÐ°Ð»ÑÐ½Ð¾Ð³Ð¾ Ð¾Ð¿Ð»Ð¾Ð´Ð¾ÑÐ²Ð¾ÑÐµÐ½Ð¸Ñ
title: Ð±Ð°ÐºÐ°Ð»Ð°Ð²ÑÑÐºÐ°Ñ ÑÐ°Ð±Ð¾ÑÐ°
titleType: Subtitle
Creators: name: ÐÑÑÐ»Ð¾Ð²Ð°, ÐÐ½Ð°ÑÑÐ°ÑÐ¸Ñ
Publisher: name: Ð¡Ð°Ð½ÐºÑ-ÐÐµÑÐµÑÐ±ÑÑÐ³ÑÐºÐ¸Ð¹ Ð¿Ð¾Ð»Ð¸ÑÐµÑÐ½Ð¸ÑÐµÑÐºÐ¸Ð¹ ÑÐ½Ð¸Ð²ÐµÑÑÐ¸ÑÐµÑ ÐÐµÑÑÐ° ÐÐµÐ»Ð¸ÐºÐ¾Ð³Ð¾
Year: 2016
Subjects: ÑÐ°ÐºÑÐ¾ÑÑ ÑÐ¾ÑÑÐ° ÑÐ½Ð´Ð¾Ð¼ÐµÑÑÐ¸Ñ
TGF-beta
GM-CSF
Ð¸Ð½ÑÐµÑÐ»ÐµÐ¹ÐºÐ¸Ð½-8
ÐºÐ¸ÑÑÐ¿ÐµÐ¿ÑÐ¸Ð½
Ð­ÐÐ
endometrial growth factors
interleukin-8
kisseptin
IVF

description: Ð Ð°Ð·ÑÐ°Ð±Ð¾ÑÐºÐ° Ð¿ÑÐ¾Ð³Ð½Ð¾ÑÑÐ¸ÑÐµÑÐºÐ¸Ñ ÐºÑÐ¸ÑÐµÑÐ¸ÐµÐ² Ð¸ÑÑÐ¾Ð´Ð° ÑÐºÑÑÑÐ°ÐºÐ¾ÑÐ¿Ð¾ÑÐ°Ð»ÑÐ½Ð¾Ð³Ð¾ Ð¾Ð¿Ð»Ð¾Ð´Ð¾ÑÐ²Ð¾ÑÐµÐ½Ð¸Ñ (Ð­ÐÐ) ÑÐ²Ð»ÑÐµÑÑÑ Ð°ÐºÑÑÐ°Ð»ÑÐ½ÑÐ¼ Ð½Ð°Ð¿ÑÐ°Ð²Ð»ÐµÐ½Ð¸ÐµÐ¼ Ð²ÑÐ¿Ð¾Ð¼Ð¾Ð³Ð°ÑÐµÐ»ÑÐ½ÑÑ ÑÐµÐ¿ÑÐ¾Ð´ÑÐºÑÐ¸Ð²Ð½ÑÑ ÑÐµÑÐ½Ð¾Ð»Ð¾Ð³Ð¸Ð¹. ÐÑÐµÐ½ÐºÐ° ÑÑÐ½ÐºÑÐ¸Ð¾Ð½Ð°Ð»ÑÐ½Ð¾ÑÑÐ¸ ÑÐ½Ð´Ð¾Ð¼ÐµÑÑÐ¸Ñ Ñ Ð¿Ð¾Ð¼Ð¾ÑÑÑ ÑÐ¿ÐµÑÐ¸ÑÐ¸ÑÐµÑÐºÐ¸Ñ ÑÐ¸Ð³Ð½Ð°Ð»ÑÐ½ÑÑ Ð¼Ð¾Ð»ÐµÐºÑÐ» Ð¿Ð¾Ð·Ð²Ð¾Ð»Ð¸Ñ ÑÑÑÐµÑÑÐ²ÐµÐ½Ð½Ð¾ Ð¿Ð¾Ð²ÑÑÐ¸ÑÑ ÑÑÑÐµÐºÑÐ¸Ð²Ð½Ð¾ÑÑÑ Ð­ÐÐ. Ð ÑÐ°Ð±Ð¾ÑÐµ Â«ÐÐ»Ð¸ÑÐ½Ð¸Ðµ ÑÐ°ÐºÑÐ¾ÑÐ¾Ð² ÑÐ¾ÑÑÐ° ÑÐ½Ð´Ð¾Ð¼ÐµÑÑÐ¸Ñ Ð½Ð° ÑÐµÐ·ÑÐ»ÑÑÐ°ÑÐ¸Ð²Ð½Ð¾ÑÑÑ ÑÐºÑÑÑÐ°ÐºÐ¾ÑÐ¿Ð¾ÑÐ°Ð»ÑÐ½Ð¾Ð³Ð¾ Ð¾Ð¿Ð»Ð¾Ð´Ð¾ÑÐ²Ð¾ÑÐµÐ½Ð¸ÑÂ» Ð±ÑÐ»Ð° Ð¸Ð·ÑÑÐµÐ½Ð° ÑÐºÑÐ¿ÑÐµÑÑÐ¸Ñ ÑÐ°ÐºÑÐ¾ÑÐ¾Ð² ÑÐ¾ÑÑÐ° TGF-Î², GM-CSF, IL-8 Ð¸ ÐºÐ¸ÑÑÐ¿ÐµÐ¿ÑÐ¸Ð½Ð° Ð² ÑÐ½Ð´Ð¾Ð¼ÐµÑÑÐ¸Ð¸ Ð¶ÐµÐ½ÑÐ¸Ð½ ÑÐ°Ð·Ð½Ð¾Ð³Ð¾ ÑÐµÐ¿ÑÐ¾Ð´ÑÐºÑÐ¸Ð²Ð½Ð¾Ð³Ð¾ Ð²Ð¾Ð·ÑÐ°ÑÑÐ° Ð² Ð·Ð°Ð²Ð¸ÑÐ¸Ð¼Ð¾ÑÑÐ¸ Ð¾Ñ Ð¸ÑÑÐ¾Ð´Ð° Ð­ÐÐ. ÐÐµÑÐ¾Ð´Ð¾Ð¼ Ð¸Ð¼Ð¼ÑÐ½Ð¾Ð³Ð¸ÑÑÐ¾ÑÐ¸Ð¼Ð¸Ð¸ Ð¸Ð·ÑÑÐ°Ð»Ð¸ ÑÐºÑÐ¿ÑÐµÑÑÐ¸Ñ ÑÐ°ÐºÑÐ¾ÑÐ¾Ð² ÑÐ¾ÑÑÐ° TGF-Î², GM-CSF, Ð¿ÑÐ¾Ð²Ð¾ÑÐ¿Ð°Ð»Ð¸ÑÐµÐ»ÑÐ½Ð¾Ð³Ð¾ ÑÐ¸ÑÐ¾ÐºÐ¸Ð½Ð° IL-8, Ð¼Ð°ÑÐºÐµÑÐ° ÑÐµÑÑÐ¸Ð»ÑÐ½Ð¾ÑÑÐ¸ ÐºÐ¸ÑÑÐ¿ÐµÐ¿ÑÐ¸Ð½Ð°. ÐÑÑÐ²Ð»ÐµÐ½Ð¾ Ð¿Ð¾Ð²ÑÑÐµÐ½Ð¸Ðµ ÑÐºÑÐ¿ÑÐµÑÑÐ¸Ð¸ ÑÐ°ÐºÑÐ¾ÑÐ¾Ð² ÑÐ¾ÑÑÐ° TGF-Î², GM-CSF Ð¸ ÐºÐ¸ÑÑÐ¿ÐµÐ¿ÑÐ¸Ð½Ð° Ð² ÑÐ½Ð´Ð¾Ð¼ÐµÑÑÐ¸Ð¸ Ñ Ð¶ÐµÐ½ÑÐ¸Ð½ Ñ Ð¿Ð¾Ð»Ð¾Ð¶Ð¸ÑÐµÐ»ÑÐ½ÑÐ¼ Ð¸ÑÑÐ¾Ð´Ð¾Ð¼ Ð­ÐÐ Ð¿Ð¾ ÑÑÐ°Ð²Ð½ÐµÐ½Ð¸Ñ Ñ ÑÐºÑÐ¿ÑÐµÑÑÐ¸ÐµÐ¹ ÑÑÐ¸Ñ Ð¼Ð¾Ð»ÐµÐºÑÐ» Ñ Ð¶ÐµÐ½ÑÐ¸Ð½ Ñ Ð¾ÑÑÐ¸ÑÐ°ÑÐµÐ»ÑÐ½ÑÐ¼ Ð¸ÑÑÐ¾Ð´Ð¾Ð¼ Ð­ÐÐ. Ð­ÐºÑÐ¿ÑÐµÑÑÐ¸Ñ IL-8 Ð² ÑÐ½Ð´Ð¾Ð¼ÐµÑÑÐ¸Ð¸ ÑÐ½Ð¸Ð¶Ð°ÐµÑÑÑ Ñ Ð¶ÐµÐ½ÑÐ¸Ð½ Ñ Ð¿Ð¾Ð»Ð¾Ð¶Ð¸ÑÐµÐ»ÑÐ½ÑÐ¼ Ð¸ÑÑÐ¾Ð´Ð¾Ð¼ Ð­ÐÐ. Ð­ÐºÑÐ¿ÑÐµÑÑÐ¸Ñ ÑÐ°ÐºÑÐ¾ÑÐ¾Ð² ÑÐ¾ÑÑÐ°, IL-8 Ð¸ ÐºÐ¸ÑÑÐ¿ÐµÐ¿ÑÐ¸Ð½Ð° Ð² ÑÐ½Ð´Ð¾Ð¼ÐµÑÑÐ¸Ð¸ Ð¶ÐµÐ½ÑÐ¸Ð½ Ð½Ðµ Ð·Ð°Ð²Ð¸ÑÐ¸Ñ Ð¾Ñ Ð²Ð¾Ð·ÑÐ°ÑÑÐ°. ÐÐ·Ð¼ÐµÐ½ÐµÐ½Ð¸Ðµ ÑÐºÑÐ¿ÑÐµÑÑÐ¸Ð¸ TGF-Î², GM-CSF, IL-8 Ð¸ ÐºÐ¸ÑÑÐ¿ÐµÐ¿ÑÐ¸Ð½Ð° Ð¼Ð¾Ð¶ÐµÑ Ð±ÑÑÑ Ð¸ÑÐ¿Ð¾Ð»ÑÐ·Ð¾Ð²Ð°Ð½Ð¾ Ð´Ð»Ñ Ð¿ÑÐµÐ´Ð¸ÐºÑÐ¸Ð²Ð½Ð¾Ð¹ Ð¾ÑÐµÐ½ÐºÐ¸ Ð¸ÑÑÐ¾Ð´Ð° Ð­ÐÐ.
description: Predictive evaluation endometrial functionality can significantly increase success of In Vitro Fertilization (IVF). In bachelor work âInfluence of endometrial growth factor on success of In Vitro Fertilizationâ expression of TGF-Î², GM-CSF, IL-8 and kisspeptin was investigated by method immunohistochemistry . As a result of research was founded that expression of TGF-Î², GM-CSF and kisspeptin increases in endometrium of women with positive IVF result. Expression of IL-8 decreases in endometrium of women with positive IVF result. Expression of TGF-Î², GM-CSF, IL-8 and kisspeptin don't depend on women age. Changes on expression of TGF-Î², GM-CSF, IL-8 and kisspeptin can be use for predictive evaluation of IVF success.